Skip to main content
Premium Trial:

Request an Annual Quote

Epistem Partners with USAF, Hopkins to Evaluate MDx System for Combat

NEW YORK (GenomeWeb News) — Epistem said yesterday that it has entered into cooperative agreements with the US Air Force and Johns Hopkins University's Advanced Physics Laboratory to undertake combat evaluation of Epistem's Genedrive molecular handheld pathogen-detection device.

The agreement provides Manchester, UK-based Epistem with $600,000 over five months to develop and evaluate Genedrive for the identification of three known disease pathogens.

Successful completion of the combat evaluation program will secure ongoing investment for Genedrive's development as a handheld pathogen-detection unit for the US Department of Defense, Epistem said.

Genedrive is a fully integrated, handheld, endpoint PCR-based system that weighs around a pound and has a footprint similar to that of a laptop computer.

The company said this week that it is preparing to launch the first Genedrive test for tuberculosis this year, and it is currently readying the final stages of clinical trials to support Indian regulatory approval.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.